-
PrEP
Wall Street Journal | 3 hours ago
The U.S. Food and Drug Administration granted Gilead Sciences Inc.'s antiretroviral drug Truvada a priority-review schedule, advancing
what could become the first treatment labeled for HIV prevention.
-
Confidentiality, consent and medical ethics
Wall Street Journal | 9 hours ago
Health officials in southern China are proposing new legislation to require real-name registration for HIV testing, a move aimed at lowering infection rates that has sparked controversy over personal privacy.
-
AIDS Free World | 20 hours ago
Invitees who attended back-to-back World Health Organization (WHO) consultations at the start of February were required to sign confidentiality agreements prohibiting them from talking about the meetings. WHO’s gag order is just the latest in a years-long effort by the United Nations’ AIDS apparatus to limit how much women know about possible links between HIV and injectable hormonal contraceptives.
-
Global health initiatives
Science Speaks: HIV & TB News | 20 hours ago
The Obama Administration released its fiscal year 2013 budget today with
a proposed $1.65 billion funding level—an increase of 26.9 percent –
for the Global Fund to Fight AIDS, Tuberculosis and Malaria to meet the
US pledge of $4 billion over 3 years. This substantial and welcome
budget request for the Global fund clearly came at the expense of
PEPFAR, the U.S.’s flagship bilateral program which is slated for a
stunning cut of $542.9 million—a reduction of almost 13 percent.
-
New and experimental hepatitis C treatment
The Street | 22 hours ago
Why is everyone obsessed with hepatitis C? Since the early 1990s, routine screening of donated blood has drastically reduced the incidence of new HCV cases; there is no ongoing epidemic of new infections to explain the excitement. Moreover, successful HCV treatment leaves patients cured, and cured patients don't need expensive drugs. Yet despite these dynamics, drug companies large and small are spending hundreds of millions of dollars seeking new HCV drugs; investors are rewarding these efforts with multi-billion-dollar market valuations.
-
Activism
The Body | 13 February 2012
When I think about the future of this epidemic 30 years from now, it scares the
hell out of me. Who is molding the next generation of black HIV leaders? If it's
progressive thinkers, then I can be somewhat hopeful. But if it's mostly the
vocal, intolerant people who attended the town hall at USCA, then we are in for
an extremely bumpy and dangerous ride.
-
Testing policies and guidelines
China Daily | 13 February 2012
Real-name HIV testing will allow health care personnel to maintain contact with HIV carriers and help carriers to prevent their intimate partners from being infected, an official with the Chinese Center for Disease Control and Prevention was quoted as saying in the Monday edition of Health News, the Ministry of Health's affiliated newspaper.
-
HIV and criminal law
Poz magazine news | 13 February 2012
Advocates in Iowa are lobbying their state legislature to change the HIV criminalization law so that a person can be prosecuted only in cases that include both an intent to transmit and an actual transmission, The Daily Iowan reports.
-
How HIV causes disease
BBC News | 12 February 2012
Scientists have shown how some cells in the body can repel attacks from HIV by starving the virus of the building blocks of life. Viruses cannot replicate on their own; they must hijack other other cells and turn them into virus production factories.
-
Types of tests
U.S. News & World Report | 10 February 2012
Many gay men who regularly have risky sex would be willing to ask partners to use a new, rapid-result HIV test, a new study shows. The tests, which use a mouth swab and detect HIV antibodies in less than 20 minutes, are currently used in testing clinics across the United States.